Evidence map›Paper›PMID 24315195›Full record

ArticleBioorganic & medicinal chemistry2014

Strategies for lead discovery: application of footprint similarity targeting HIVgp41.

Patrick M Holden, William J Allen, Miriam Gochin, Robert C Rizzo

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Mutations in Mig6 reduce inhibition of the epidermal growth factor receptor.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  2. Article
  3. Article
  4. A molecular evolution algorithm for ligand design in DOCK.Journal of computational chemistry · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation.Bioorganic & medicinal chemistry letters · 2015
    Article
  14. Pharmacophore-based similarity scoring for DOCK.The journal of physical chemistry. B · 2015
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Patrick M HoldenDepartment of Applied Mathematics & Statistics, Stony Brook University, Stony Brook, NY 11794, United States.
William J AllenDepartment of Applied Mathematics & Statistics, Stony Brook University, Stony Brook, NY 11794, United States.
Miriam GochinDepartment of Basic Sciences, Touro University-California, Mare Island, Vallejo, CA 94592, United States; Department of Pharmaceutical Chemistry, University of California San Francisco, CA 94143, United States.
Robert C RizzoDepartment of Applied Mathematics & Statistics, Stony Brook University, Stony Brook, NY 11794, United States; Institute of Chemical Biology & Drug Discovery, Stony Brook University, Stony Brook, NY 11794, United States; Laufer Center for Physical & Quantitative Biology, Stony Brook University, Stony Brook, NY 11794, United States. Electronic address: rizzorc@gmail.com.
Stony Brook University · USUniversity of California, San Francisco · US

Funding

Computational Design of Fusion Inhibitors Targeting Drug-resistant HIVgp41R01GM083669 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI RIZZO, ROBERT C. · 2008 to 2016
$2.6M
Structure-based discovery and development of HIV-1 gp41 fusion inhibitorsR01GM087998 · NIGMS · TOURO UNIVERSITY OF CALIFORNIA · PI GOCHIN, MIRIAM · 2010 to 2013
$1.1M
Ligand-based Design of Anti-HIV Therapeutics Targeting gp41F32GM105400 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI ALLEN, WILLIAM J · 2013 to 2014
$102k
NIGMS NIH HHS 32GM105400NIGMS NIH HHS F32 GM105400NIGMS NIH HHS R01 GM083669NIGMS NIH HHS R01GM083669NIGMS NIH HHS R01 GM087998NIGMS NIH HHS R01GM087998
6 · The paper itself

Abstract

A highly-conserved binding pocket on HIVgp41 is an important target for development of anti-viral inhibitors. Holden et al. (Bioorg. Med. Chem. Lett.2012, 22, 3011) recently reported 7 experimentally-verified leads identified through a computational screen to the gp41 pocket in conjunction with a new DOCK scoring method (termed FPS scoring) developed in our laboratory. The method employs molecular footprints based on per-residue van der Waals interactions, electrostatic interactions, or the sum. In this work, we critically examine the gp41 screening results, prioritized using different scoring methods, in terms of two main criteria: (1) ligand pose properties which include footprint and energy score decompositions, MW, number of rotatable bonds, ligand efficiency, formal charge, and volume overlap, and (2) ligand pose stability which includes footprint stability (changes in footprint overlap) and rmsd stability (changes in geometry). Relative to standard DOCK scoring, pose property analyses demonstrate how FPS scoring can be used to identify ligands that mimic a known reference (derived here from the native gp41 substrate), while pose stability analyses demonstrate how FPS scoring can be used to enrich for compounds with greater overall stability during molecular dynamics (MD) simulations. Compellingly, of the 115 compounds tested experimentally, the 7 active compounds, as a group, more closely mimic the footprints made by the reference and show greater MD stability compared to the inactive group. Extensive studies using 116 protein-ligand complexes as controls reveal that ligands in their crystallographic binding pose also maintain higher FPS scores and smaller rmsds than do accompanying decoys, confirming that native poses are indeed 'stable' under the same conditions and that monitoring FPS variability during compound prioritization is likely to be beneficial. Overall, the results suggest the new scoring method will complement current virtual screening approaches for both the identification (FPS-ranking) and prioritization (FPS-stability) of target-compatible molecules in a quantitative and logical way.

Indexed as

Anti-HIV AgentsDrug DesignHIVHIV Envelope Protein gp41HumansModels, MolecularMolecular Docking SimulationProtein BindingAnti-HIV AgentsHIV Envelope Protein gp41DCEDOCKDOCK Cartesian energyDockingelectrostaticESfootprint similarityFootprint similarityFPSglycoprotein-41gp41HIVMDmolecular dynamicsMolecular dynamicsProtein–protein interactionsSASAScoring functionssolvent accessible surface areavan der WaalsVDWVirtual screening

Identifiers

PMID24315195
PMCPMC3913180
OpenAlexW1964567511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.